Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv

A Visa credit card is seen on a computer keyboard in this picture illustration taken September 6, 2017. REUTERS/Philippe Wojazer/Illustration/File Photo Purchase Licensing Rights, opens new tab
-
Companies
Follow
Follow
Follow
Aug 3 (Reuters) - Visa (V.N), opens new tab said on Monday it would buy fraud intelligence provider BioCatch for $2.4 billion in cash from investment firm Permira and other investors, marking the card giant's latest effort to beef up its cybersecurity offerings.
The deal would help the world's largest payment processor further bolster its existing cyber, fraud, risk and security offerings and enable it to help clients better protect themselves in an increasingly complex threat environment, Visa said.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Advertisement · Scroll to continue
"Account takeovers and scams cost the global economy over $1 trillion annually and AI is enabling these attacks at unprecedented scale. BioCatch will help our clients stop fraud before it reaches the point of payment," said Andrew Torre, president of value-added services at Visa.
Founded in 2011, BioCatch helps detect fraud and distinguish legitimate users from fraudsters in real time by analyzing signals such as keystrokes, touch gestures and device handling.
The firm serves more than 350 banking clients in 21 countries and offers protection to 1.8 billion devices and 760 million users around the world.
Advertisement · Scroll to continue
Card giants have increasingly turned to acquisitions to bolster their fraud prevention offerings in recent years.
Mastercard (MA.N), opens new tab finalized a $2.65 billion acquisition of threat intelligence company Recorded Future in 2024, while Visa bought payments protection firm Featurespace the same year.
Over the last five years, Visa has invested more than $13 billion in technology and infrastructure to tackle fraudsters.
The BioCatch deal is expected to close by the end of Visa's fiscal second quarter of 2027.
Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Joyjeet Das and Shinjini Ganguli
Our Standards: The Thomson Reuters Trust Principles., opens new tab
-
X
-
Facebook
-
Linkedin
-
Email
-
Link
Read Next / Editor's Picks
- 4 hours agoGovernmentcategory
Which midterm candidates is the crypto industry backing?
- July 31, 2026Worldcategory
US Commodity Futures Trading Commission fines George Santos for alleged manipulative trading
- July 31, 2026Businesscategory
US Treasury anti-money laundering chief Gacki to join Citi as global head of sanctions
- July 31, 2026Transactionalcategory
US bank regulators propose fair-lending rule update
- July 30, 2026Governmentcategory
Delaware judge rules public benefit corporations exempt from maximizing value in sale
- 2 hours agoLitigationcategory
Sandoz agrees $450 mln settlement with 43 US states over antitrust claims
- July 28, 2026Worldcategory
Judge blocks Minnesota's first-in-nation prediction markets ban
- 14 mins agoWorldcategory
EXCLUSIVE
French broadcaster TF1 weighs sale of production arm Studio TF1, sources say
- 19 mins agoTransactionalcategory
Amazon enters $3 trillion club as AI, cloud growth power rally
- 2 mins agoWorldcategory
UBS fined $125 million by US regulators for money laundering violations
- 52 mins agoTransactionalcategory
Robinhood's second private markets fund targets $200 million US IPO
- 1 hour agoLitigationcategory
Base Power raises $1 billion, launches US-made home battery amid surging power demand
- 1 hour agoWorldcategory
US farm agency staff warn trade, research, aid programs at risk from reorganization
- 2 mins agoTransactionalcategory
Latigo, BlossomHill launch US IPOs as biotech listings rebound
- 1 hour agoTransactionalcategory
American Family to buy remaining stake in specialty insurer Bowhead in $1.2 billion deal
Read Original at Reuters →















